USANA Financial Statements From 2010 to 2026

USNA Stock  USD 20.55  1.55  8.16%   
USANA Health's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing USANA Health's valuation are provided below:
Gross Profit
722.7 M
Profit Margin
0.0186
Market Capitalization
347.3 M
Enterprise Value Revenue
0.247
Revenue
912.7 M
We have found one hundred twenty available fundamental measures for USANA Health, which can be analyzed and compared to other ratios and to its peers in the sector. All investors should make sure to double-check all of USANA Health latest market performance against the performance between 2010 and 2026 to make sure the company can sustain itself next year. The current year's Market Cap is expected to grow to about 1.5 B. The current year's Enterprise Value is expected to grow to about 1.3 B

USANA Health Total Revenue

610.47 Million

Check USANA Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among USANA Health's main balance sheet or income statement drivers, such as Interest Expense of 884.1 K, Total Revenue of 610.5 M or Gross Profit of 492 M, as well as many indicators such as Price To Sales Ratio of 1.12, Dividend Yield of 0.0 or PTB Ratio of 2.08. USANA financial statements analysis is a perfect complement when working with USANA Health Valuation or Volatility modules.
  
Build AI portfolio with USANA Stock
Check out the analysis of USANA Health Correlation against competitors.

USANA Health Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding26.6 M18.6 M25 M
Slightly volatile
Total Assets903.4 M860.4 M510.9 M
Slightly volatile
Other Current Liabilities61.3 M86 M89.9 M
Pretty Stable
Total Current Liabilities168.6 M160.6 M123.2 M
Slightly volatile
Total Stockholder Equity642.5 M611.9 M360.2 M
Slightly volatile
Property Plant And Equipment Net65.3 M108.7 M88.7 M
Slightly volatile
Retained Earnings578.3 M550.8 M305.7 M
Slightly volatile
Accounts Payable8.4 M13.8 M10.2 M
Slightly volatile
Cash106.2 M209 M179.8 M
Slightly volatile
Non Current Assets Total566.3 M539.4 M230.4 M
Slightly volatile
Non Currrent Assets Other67.7 M64.5 M25.6 M
Slightly volatile
Cash And Short Term Investments108.9 M209 M184.2 M
Slightly volatile
Liabilities And Stockholders Equity903.4 M860.4 M510.9 M
Slightly volatile
Inventory41.9 M80.2 M60.1 M
Slightly volatile
Other Current Assets15.6 M22.4 M22.1 M
Pretty Stable
Other Stockholder Equity91.5 M87.2 M62 M
Slightly volatile
Total Liabilities195.4 M186.1 M140 M
Slightly volatile
Property Plant And Equipment Gross271.3 M258.4 M128 M
Slightly volatile
Total Current Assets169.6 M321.1 M270.7 M
Slightly volatile
Short and Long Term Debt Total47.3 M45.1 M25.4 M
Slightly volatile
Net Receivables6.8 M9.5 M9.4 M
Very volatile
Non Current Liabilities Total13.3 M25.6 M16 M
Slightly volatile
Short Term Debt35 M33.4 M16.2 M
Slightly volatile
Common Stock16.2 K17.1 K417.3 K
Slightly volatile
Property Plant Equipment68 M128.4 M87.3 M
Slightly volatile
Other Liabilities7.1 M12.1 M8.8 M
Slightly volatile
Good Will174.1 M165.8 M42 M
Slightly volatile
Intangible Assets183.3 M174.6 M57.4 M
Slightly volatile
Net Tangible Assets297.1 M442.4 M286.1 M
Slightly volatile
Capital Surpluse67 M57.5 M59 M
Very volatile
Non Current Liabilities Other21.9 M20.9 M8.8 M
Slightly volatile
Deferred Long Term Asset Charges2.9 MM6.1 M
Slightly volatile
Net Invested Capital471.7 M638.4 M416.6 M
Slightly volatile
Net Working Capital177.6 M125.6 M204.3 M
Very volatile
Capital Stock16.3 K17.1 K21.7 K
Slightly volatile
Capital Lease Obligations5.9 M5.4 M7.7 M
Slightly volatile
Short and Long Term Debt27.8 M26.4 M5.2 M
Slightly volatile

USANA Health Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Total Revenue610.5 M925.3 M858.8 M
Slightly volatile
Gross Profit492 M724.4 M699.6 M
Slightly volatile
Operating Income35.6 M37.4 M108.8 M
Very volatile
EBIT81.3 M88.1 M115.7 M
Pretty Stable
EBITDA35.6 M37.4 M123.1 M
Very volatile
Net Income10.2 M10.8 M70.3 M
Very volatile
Depreciation And Amortization26.8 M25.6 M16.2 M
Slightly volatile
Other Operating Expenses540.6 M687 M737.4 M
Slightly volatile
Research Development14 M13.3 M8.6 M
Slightly volatile
Cost Of Revenue122.3 M200.9 M159.8 M
Slightly volatile
Total Operating Expenses418.4 M486.1 M577.6 M
Slightly volatile
Income Before Tax39.5 M41.5 M111 M
Very volatile
Selling General Administrative223 M297 M237.2 M
Slightly volatile
Net Income Applicable To Common Shares65.4 M79.8 M79.7 M
Slightly volatile
Net Income From Continuing Ops91.9 M48.4 M80 M
Very volatile
Selling And Marketing Expenses461.9 M424 M406.2 M
Slightly volatile
Tax Provision39.5 M30.9 M47.3 M
Slightly volatile
Interest Income13.7 M13 M4.4 M
Slightly volatile
Net Interest Income13.3 M12.7 M4.2 M
Slightly volatile
Reconciled Depreciation22.7 M25.6 M19.2 M
Slightly volatile

USANA Health Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow402.4 M383.2 M199.3 M
Slightly volatile
Depreciation26.8 M25.6 M16.2 M
Slightly volatile
Capital Expenditures12.2 M11.6 M13.9 M
Very volatile
Total Cash From Operating Activities73 M70.1 M99 M
Very volatile
Net Income55.1 M48.4 M75.2 M
Pretty Stable
End Period Cash Flow107.1 M212.2 M181.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.120.39021.2413
Very volatile
PTB Ratio2.080.67733.4958
Pretty Stable
Days Sales Outstanding3.112.573.8852
Slightly volatile
Book Value Per Share25.8331.564118.3719
Slightly volatile
Free Cash Flow Yield0.0550.0490.0759
Slightly volatile
Operating Cash Flow Per Share2.123.34.4522
Pretty Stable
Stock Based Compensation To Revenue0.01650.01820.0147
Pretty Stable
Capex To Depreciation0.780.821.0381
Slightly volatile
PB Ratio2.080.67733.4958
Pretty Stable
EV To Sales0.780.23421.0443
Pretty Stable
Free Cash Flow Per Share1.792.633.8206
Pretty Stable
ROIC0.110.01540.2065
Slightly volatile
Inventory Turnover3.081.95752.7518
Pretty Stable
Net Income Per Share3.310.57933.1724
Pretty Stable
Days Of Inventory On Hand118186137
Pretty Stable
Payables Turnover18.8111.634816.3917
Very volatile
Research And Ddevelopement To Revenue0.01020.01430.0096
Slightly volatile
Capex To Revenue0.01720.01810.0163
Pretty Stable
Cash Per Share17.168.5279.4665
Slightly volatile
POCF Ratio9.7813.1512.1347
Slightly volatile
Capex To Operating Cash Flow0.40.240.1646
Slightly volatile
PFCF Ratio17.3716.5414.6653
Slightly volatile
Days Payables Outstanding19.4131.371323.2282
Very volatile
Income Quality1.641.271.3409
Pretty Stable
ROE0.130.02020.2215
Slightly volatile
EV To Operating Cash Flow12.6511.6310.4985
Slightly volatile
PE Ratio16.1833.557519.0729
Slightly volatile
Return On Tangible Assets0.110.02280.1795
Slightly volatile
EV To Free Cash Flow12.0311.4512.0178
Pretty Stable
Earnings Yield0.06180.02980.063
Slightly volatile
Intangibles To Total Assets0.07430.36490.1652
Pretty Stable
Current Ratio3.522.24332.3705
Slightly volatile
Tangible Book Value Per Share23.3916.967813.9449
Slightly volatile
Receivables Turnover131147107
Slightly volatile
Graham Number43.8819.341832.657
Slightly volatile
Shareholders Equity Per Share25.8328.701617.8668
Slightly volatile
Debt To Equity0.02660.02630.0317
Pretty Stable
Capex Per Share0.710.680.6546
Slightly volatile
Graham Net Net12.02.85574.7545
Slightly volatile
Revenue Per Share47.8449.814642.8639
Slightly volatile
Interest Debt Per Share0.70.70840.4305
Slightly volatile
Debt To Assets0.02090.01880.0227
Pretty Stable
Enterprise Value Over EBITDA5.85.78917.5587
Very volatile
Short Term Coverage Ratios84.9380.8925.6162
Slightly volatile
Price Earnings Ratio16.1833.557519.0729
Slightly volatile
Operating Cycle121186140
Pretty Stable
Price Book Value Ratio2.080.67733.4958
Pretty Stable
Days Of Payables Outstanding19.4131.371323.2282
Very volatile
Price To Operating Cash Flows Ratio9.7813.1512.1347
Slightly volatile
Price To Free Cash Flows Ratio17.3716.5414.6653
Slightly volatile
Pretax Profit Margin0.110.04490.1226
Slightly volatile
Ebt Per Ebit1.11.10941.0364
Slightly volatile
Operating Profit Margin0.10.04050.1199
Slightly volatile
Effective Tax Rate0.380.74090.4181
Pretty Stable
Company Equity Multiplier1.271.39361.4157
Slightly volatile
Long Term Debt To Capitalization0.0940.09890.1038
Slightly volatile
Total Debt To Capitalization0.02590.02560.0306
Pretty Stable
Return On Capital Employed0.180.06090.323
Slightly volatile
Debt Equity Ratio0.02660.02630.0317
Pretty Stable
Ebit Per Revenue0.10.04050.1199
Slightly volatile
Quick Ratio3.01.44521.8081
Slightly volatile
Dividend Paid And Capex Coverage Ratio5.024.397.6213
Pretty Stable
Net Income Per E B T0.620.25910.5819
Pretty Stable
Cash Ratio2.781.23191.5405
Slightly volatile
Cash Conversion Cycle102155117
Pretty Stable
Operating Cash Flow Sales Ratio0.0960.0690.1115
Slightly volatile
Days Of Inventory Outstanding118186137
Pretty Stable
Days Of Sales Outstanding3.112.573.8852
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.510.720.8278
Slightly volatile
Cash Flow Coverage Ratios2.694.813.4806
Slightly volatile
Price To Book Ratio2.080.67733.4958
Pretty Stable
Fixed Asset Turnover9.239.80329.9896
Slightly volatile
Capital Expenditure Coverage Ratio5.024.397.6213
Pretty Stable
Price Cash Flow Ratio9.7813.1512.1347
Slightly volatile
Enterprise Value Multiple5.85.78917.5587
Very volatile
Debt Ratio0.02090.01880.0227
Pretty Stable
Cash Flow To Debt Ratio2.694.813.4806
Slightly volatile
Price Sales Ratio1.120.39021.2413
Very volatile
Return On Assets0.10.01450.1544
Slightly volatile
Asset Turnover1.461.24541.8634
Slightly volatile
Net Profit Margin0.06930.01160.0771
Slightly volatile
Gross Profit Margin0.790.78290.8024
Slightly volatile
Price Fair Value2.080.67733.4958
Pretty Stable
Return On Equity0.130.02020.2215
Slightly volatile

USANA Health Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap1.5 B1.5 B1.5 B
Slightly volatile
Enterprise Value1.3 B1.2 B1.2 B
Slightly volatile

USANA Fundamental Market Drivers

USANA Upcoming Events

6th of February 2024
Upcoming Quarterly Report
View
23rd of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About USANA Health Financial Statements

USANA Health stakeholders use historical fundamental indicators, such as USANA Health's revenue or net income, to determine how well the company is positioned to perform in the future. Although USANA Health investors may analyze each financial statement separately, they are all interrelated. For example, changes in USANA Health's assets and liabilities are reflected in the revenues and expenses on USANA Health's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in USANA Health Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue13.9 M12 M
Total Revenue925.3 M610.5 M
Cost Of Revenue200.9 M122.3 M
Stock Based Compensation To Revenue 0.02  0.02 
Research And Ddevelopement To Revenue 0.01  0.01 
Capex To Revenue 0.02  0.02 
Revenue Per Share 49.81  47.84 
Ebit Per Revenue 0.04  0.10 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out the analysis of USANA Health Correlation against competitors.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive USANA Health assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.04)
Earnings Share
0.9
Revenue Per Share
48.713
Quarterly Revenue Growth
0.067
Return On Assets
0.0374
Understanding USANA Health Sciences requires distinguishing between market price and book value, where the latter reflects USANA's accounting equity. The concept of intrinsic value - what USANA Health's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push USANA Health's price substantially above or below its fundamental value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, USANA Health's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.